In conversation with... Ellisiv Mathiesen

from Listen to The Lancet Neurology · host The Lancet

Ellisiv Mathiesen (The University of Tromsø – the Arctic University of Norway, Tromsø, Norway) discusses the findings of the TWIST trial, which investigated the use of tenecteplase for patients with wake-up stroke who were selected for treatment by non-contrast CT. This Fast-track Article is published in the February issue of The Lancet Neurology.

Episode metadata supplied by the publisher feed · Published Jan 20, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

In conversation with... Ellisiv Mathiesen

0:00 8:45

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Listen to The Lancet Neurology?

This episode is 8 minutes long.

When was this Listen to The Lancet Neurology episode published?

This episode was published on January 20, 2023.

Can I download this Listen to The Lancet Neurology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!